Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)

Open Posted

Opportunity number
RFA-HL-26-012
Agency
Applications due
Award size
Not on record

Opportunity facts

Funding instrument
Grant
Category
  • Health
Eligible applicants
  • Non-501(c)(3) Nonprofits
  • Tribal Governments (Federally Recognized)
  • Tribal Organizations (Not Federally Recognized)
  • County Governments
  • Independent School Districts
  • City/Township Governments
  • Special District Governments
  • Higher Education Inst. (Public)
  • Small Businesses
  • Public or Indian Housing Auth.
  • Higher Education Inst. (Private)
  • State Governments
  • For Profit Organizations
  • 501(c)(3) Nonprofits
  • Other
Points of contact
Full announcement

Opportunity details come from Grants.gov. Updated .

About this opportunity

Written by GovTribe AI ·

The National Institutes of Health (NHLBI, NIAID, NIA, and NEI) intends to solicit applications for the Stimulating Access to Research in Residency (StARR) program with an application due date of January 10, 2028. This is a forecast announcement; applications are not yet being solicited. The program uses the R38 activity code and will be awarded as grants.

Eligible applicants include non-501(c)(3) nonprofits, 501(c)(3) nonprofits, tribal governments (federally recognized and non-federally recognized), county governments, independent school districts, city and township governments, special district governments, public and private higher education institutions, small businesses, public or Indian housing authorities, state governments, for-profit organizations, federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions. Non-domestic (non-U.S.) entities and foreign components of U.S. organizations are not eligible.

The program's overall goal is to provide resident clinicians in training with in-depth research experiences early in their careers to recruit, retain, and accelerate independence of clinician-investigators capable of performing basic, clinical, and translational research. The program will fund research across four institutes: NHLBI (CFDA 93.837), NIAID (CFDA 93.855), NIA (CFDA 93.866), and NEI (CFDA 93.867).

The source does not specify award ceilings, award floors, expected number of awards, period of performance, place of performance, cost-share requirements, evaluation criteria, weighting of criteria, or specific priority research areas. Interested parties are encouraged to begin developing meaningful collaborations and responsive projects in advance of the NOFO publication.

Synopsis

The overall goal of the Stimulating Access to Research in Residency (StARR) program is to provide resident clinicians in training with in-depth research experiences early in their careers, in order to recruit, retain and accelerate independence of a pool of clinician-investigators with both clinical and research experience necessary to perform basic, clinical and/or translational research.

Eligibility

Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Files

File Type Posted
RFA-HL-26-012-Full-Announcement.html HTML file
PKG00291398.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login